img

Global Synthetic Oligonucleotides Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Synthetic Oligonucleotides Market Insights, Forecast to 2034

The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development.
Market Analysis and InsightsGlobal Synthetic Oligonucleotides Market
Global Synthetic Oligonucleotides market is expected to reach to US$ 7541 million in 2023, with a positive growth of %, compared with US$ 6782 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Synthetic Oligonucleotides industry is evaluated to reach US$ 14260 million in 2033. The CAGR will be 11.2% during 2023 to 2033.
Globally, Synthetic Oligonucleotides key companies include Merck KGaA, Thermo Fisher Scientific, Creative Biolabs, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., GE Healthcare, Kaneka Eurogentec S.A. and GeneDesign, Inc., etc. Merck KGaA, Thermo Fisher Scientific, Creative Biolabs are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Synthetic Oligonucleotides were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Synthetic Oligonucleotides market and estimated to attract more attentions from industry insiders and investors.
Synthetic Oligonucleotides can be divided into Column-Based Oligos and Array-Based Oligos, etc. Column-Based Oligos is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Synthetic Oligonucleotides is widely used in various fields, such as Genetic Testing, Pharmacy and Other,, etc. Genetic Testing provides greatest supports to the Synthetic Oligonucleotides industry development. In 2022, global % revenue of Synthetic Oligonucleotides went into Genetic Testing filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Synthetic Oligonucleotides market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Synthetic Oligonucleotides market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Thermo Fisher Scientific
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Agilent Technologies, Inc.
GE Healthcare
Kaneka Eurogentec S.A.
GeneDesign, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
GeneWorks Pty Ltd
Integrated DNA Technologies, Inc
BioAutomation
Twist Bioscience
Segment by Type
Column-Based Oligos
Array-Based Oligos

Segment by Application


Genetic Testing
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Synthetic Oligonucleotides introduction, etc. Synthetic Oligonucleotides Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Synthetic Oligonucleotides
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Oligonucleotides Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Column-Based Oligos
1.2.3 Array-Based Oligos
1.3 Market by Application
1.3.1 Global Synthetic Oligonucleotides Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Genetic Testing
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Oligonucleotides Market Perspective (2018-2033)
2.2 Global Synthetic Oligonucleotides Growth Trends by Region
2.2.1 Synthetic Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Synthetic Oligonucleotides Historic Market Size by Region (2018-2023)
2.2.3 Synthetic Oligonucleotides Forecasted Market Size by Region (2024-2033)
2.3 Synthetic Oligonucleotides Market Dynamics
2.3.1 Synthetic Oligonucleotides Industry Trends
2.3.2 Synthetic Oligonucleotides Market Drivers
2.3.3 Synthetic Oligonucleotides Market Challenges
2.3.4 Synthetic Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Synthetic Oligonucleotides by Players
3.1.1 Global Synthetic Oligonucleotides Revenue by Players (2018-2023)
3.1.2 Global Synthetic Oligonucleotides Revenue Market Share by Players (2018-2023)
3.2 Global Synthetic Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Synthetic Oligonucleotides, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Synthetic Oligonucleotides Market Concentration Ratio
3.4.1 Global Synthetic Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Oligonucleotides Revenue in 2022
3.5 Global Key Players of Synthetic Oligonucleotides Head office and Area Served
3.6 Global Key Players of Synthetic Oligonucleotides, Product and Application
3.7 Global Key Players of Synthetic Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Oligonucleotides Breakdown Data by Type
4.1 Global Synthetic Oligonucleotides Historic Market Size by Type (2018-2023)
4.2 Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033)
5 Synthetic Oligonucleotides Breakdown Data by Application
5.1 Global Synthetic Oligonucleotides Historic Market Size by Application (2018-2023)
5.2 Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Synthetic Oligonucleotides Market Size (2018-2033)
6.2 North America Synthetic Oligonucleotides Market Size by Type
6.2.1 North America Synthetic Oligonucleotides Market Size by Type (2018-2023)
6.2.2 North America Synthetic Oligonucleotides Market Size by Type (2024-2033)
6.2.3 North America Synthetic Oligonucleotides Market Share by Type (2018-2033)
6.3 North America Synthetic Oligonucleotides Market Size by Application
6.3.1 North America Synthetic Oligonucleotides Market Size by Application (2018-2023)
6.3.2 North America Synthetic Oligonucleotides Market Size by Application (2024-2033)
6.3.3 North America Synthetic Oligonucleotides Market Share by Application (2018-2033)
6.4 North America Synthetic Oligonucleotides Market Size by Country
6.4.1 North America Synthetic Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Synthetic Oligonucleotides Market Size by Country (2018-2023)
6.4.3 North America Synthetic Oligonucleotides Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Synthetic Oligonucleotides Market Size (2018-2033)
7.2 Europe Synthetic Oligonucleotides Market Size by Type
7.2.1 Europe Synthetic Oligonucleotides Market Size by Type (2018-2023)
7.2.2 Europe Synthetic Oligonucleotides Market Size by Type (2024-2033)
7.2.3 Europe Synthetic Oligonucleotides Market Share by Type (2018-2033)
7.3 Europe Synthetic Oligonucleotides Market Size by Application
7.3.1 Europe Synthetic Oligonucleotides Market Size by Application (2018-2023)
7.3.2 Europe Synthetic Oligonucleotides Market Size by Application (2024-2033)
7.3.3 Europe Synthetic Oligonucleotides Market Share by Application (2018-2033)
7.4 Europe Synthetic Oligonucleotides Market Size by Country
7.4.1 Europe Synthetic Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Synthetic Oligonucleotides Market Size by Country (2018-2023)
7.4.3 Europe Synthetic Oligonucleotides Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Synthetic Oligonucleotides Market Size (2018-2033)
8.2 China Synthetic Oligonucleotides Market Size by Type
8.2.1 China Synthetic Oligonucleotides Market Size by Type (2018-2023)
8.2.2 China Synthetic Oligonucleotides Market Size by Type (2024-2033)
8.2.3 China Synthetic Oligonucleotides Market Share by Type (2018-2033)
8.3 China Synthetic Oligonucleotides Market Size by Application
8.3.1 China Synthetic Oligonucleotides Market Size by Application (2018-2023)
8.3.2 China Synthetic Oligonucleotides Market Size by Application (2024-2033)
8.3.3 China Synthetic Oligonucleotides Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Synthetic Oligonucleotides Market Size (2018-2033)
9.2 Asia Synthetic Oligonucleotides Market Size by Type
9.2.1 Asia Synthetic Oligonucleotides Market Size by Type (2018-2023)
9.2.2 Asia Synthetic Oligonucleotides Market Size by Type (2024-2033)
9.2.3 Asia Synthetic Oligonucleotides Market Share by Type (2018-2033)
9.3 Asia Synthetic Oligonucleotides Market Size by Application
9.3.1 Asia Synthetic Oligonucleotides Market Size by Application (2018-2023)
9.3.2 Asia Synthetic Oligonucleotides Market Size by Application (2024-2033)
9.3.3 Asia Synthetic Oligonucleotides Market Share by Application (2018-2033)
9.4 Asia Synthetic Oligonucleotides Market Size by Region
9.4.1 Asia Synthetic Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Synthetic Oligonucleotides Market Size by Region (2018-2023)
9.4.3 Asia Synthetic Oligonucleotides Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Type
10.2.1 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Application
10.3.1 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country
10.4.1 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Synthetic Oligonucleotides Introduction
11.1.4 Merck KGaA Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.1.5 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Synthetic Oligonucleotides Introduction
11.2.4 Thermo Fisher Scientific Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Synthetic Oligonucleotides Introduction
11.3.4 Creative Biolabs Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.3.5 Creative Biolabs Recent Developments
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Synthetic Oligonucleotides Introduction
11.4.4 Danaher Corporation Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.4.5 Danaher Corporation Recent Developments
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Synthetic Oligonucleotides Introduction
11.5.4 Eurofins Scientific SE Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.5.5 Eurofins Scientific SE Recent Developments
11.6 Agilent Technologies, Inc.
11.6.1 Agilent Technologies, Inc. Company Details
11.6.2 Agilent Technologies, Inc. Business Overview
11.6.3 Agilent Technologies, Inc. Synthetic Oligonucleotides Introduction
11.6.4 Agilent Technologies, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.6.5 Agilent Technologies, Inc. Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Synthetic Oligonucleotides Introduction
11.7.4 GE Healthcare Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.7.5 GE Healthcare Recent Developments
11.8 Kaneka Eurogentec S.A.
11.8.1 Kaneka Eurogentec S.A. Company Details
11.8.2 Kaneka Eurogentec S.A. Business Overview
11.8.3 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Introduction
11.8.4 Kaneka Eurogentec S.A. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.8.5 Kaneka Eurogentec S.A. Recent Developments
11.9 GeneDesign, Inc.
11.9.1 GeneDesign, Inc. Company Details
11.9.2 GeneDesign, Inc. Business Overview
11.9.3 GeneDesign, Inc. Synthetic Oligonucleotides Introduction
11.9.4 GeneDesign, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.9.5 GeneDesign, Inc. Recent Developments
11.10 LGC Biosearch Technologies
11.10.1 LGC Biosearch Technologies Company Details
11.10.2 LGC Biosearch Technologies Business Overview
11.10.3 LGC Biosearch Technologies Synthetic Oligonucleotides Introduction
11.10.4 LGC Biosearch Technologies Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.10.5 LGC Biosearch Technologies Recent Developments
11.11 Bio-synthesis Inc.
11.11.1 Bio-synthesis Inc. Company Details
11.11.2 Bio-synthesis Inc. Business Overview
11.11.3 Bio-synthesis Inc. Synthetic Oligonucleotides Introduction
11.11.4 Bio-synthesis Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.11.5 Bio-synthesis Inc. Recent Developments
11.12 GeneWorks Pty Ltd
11.12.1 GeneWorks Pty Ltd Company Details
11.12.2 GeneWorks Pty Ltd Business Overview
11.12.3 GeneWorks Pty Ltd Synthetic Oligonucleotides Introduction
11.12.4 GeneWorks Pty Ltd Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.12.5 GeneWorks Pty Ltd Recent Developments
11.13 Integrated DNA Technologies, Inc
11.13.1 Integrated DNA Technologies, Inc Company Details
11.13.2 Integrated DNA Technologies, Inc Business Overview
11.13.3 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Introduction
11.13.4 Integrated DNA Technologies, Inc Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.13.5 Integrated DNA Technologies, Inc Recent Developments
11.14 BioAutomation
11.14.1 BioAutomation Company Details
11.14.2 BioAutomation Business Overview
11.14.3 BioAutomation Synthetic Oligonucleotides Introduction
11.14.4 BioAutomation Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.14.5 BioAutomation Recent Developments
11.15 Twist Bioscience
11.15.1 Twist Bioscience Company Details
11.15.2 Twist Bioscience Business Overview
11.15.3 Twist Bioscience Synthetic Oligonucleotides Introduction
11.15.4 Twist Bioscience Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.15.5 Twist Bioscience Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Synthetic Oligonucleotides Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Column-Based Oligos
Table 3. Key Players of Array-Based Oligos
Table 4. Global Synthetic Oligonucleotides Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Synthetic Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Synthetic Oligonucleotides Market Share by Region (2018-2023)
Table 8. Global Synthetic Oligonucleotides Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Synthetic Oligonucleotides Market Share by Region (2024-2033)
Table 10. Synthetic Oligonucleotides Market Trends
Table 11. Synthetic Oligonucleotides Market Drivers
Table 12. Synthetic Oligonucleotides Market Challenges
Table 13. Synthetic Oligonucleotides Market Restraints
Table 14. Global Synthetic Oligonucleotides Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Synthetic Oligonucleotides Revenue Share by Players (2018-2023)
Table 16. Global Top Synthetic Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
Table 17. Global Synthetic Oligonucleotides Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Synthetic Oligonucleotides Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Synthetic Oligonucleotides, Headquarters and Area Served
Table 20. Global Key Players of Synthetic Oligonucleotides, Product and Application
Table 21. Global Key Players of Synthetic Oligonucleotides, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Synthetic Oligonucleotides Revenue Market Share by Type (2018-2023)
Table 25. Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Synthetic Oligonucleotides Revenue Market Share by Type (2024-2033)
Table 27. Global Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Synthetic Oligonucleotides Revenue Share by Application (2018-2023)
Table 29. Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Synthetic Oligonucleotides Revenue Share by Application (2024-2033)
Table 31. North America Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Synthetic Oligonucleotides Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Synthetic Oligonucleotides Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Synthetic Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Synthetic Oligonucleotides Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Synthetic Oligonucleotides Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Synthetic Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Synthetic Oligonucleotides Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Synthetic Oligonucleotides Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Synthetic Oligonucleotides Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Synthetic Oligonucleotides Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Synthetic Oligonucleotides Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Synthetic Oligonucleotides Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Synthetic Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Synthetic Oligonucleotides Product
Table 66. Merck KGaA Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 67. Merck KGaA Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Synthetic Oligonucleotides Product
Table 71. Thermo Fisher Scientific Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Creative Biolabs Company Details
Table 74. Creative Biolabs Business Overview
Table 75. Creative Biolabs Synthetic Oligonucleotides Product
Table 76. Creative Biolabs Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 77. Creative Biolabs Recent Developments
Table 78. Danaher Corporation Company Details
Table 79. Danaher Corporation Business Overview
Table 80. Danaher Corporation Synthetic Oligonucleotides Product
Table 81. Danaher Corporation Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 82. Danaher Corporation Recent Developments
Table 83. Eurofins Scientific SE Company Details
Table 84. Eurofins Scientific SE Business Overview
Table 85. Eurofins Scientific SE Synthetic Oligonucleotides Product
Table 86. Eurofins Scientific SE Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 87. Eurofins Scientific SE Recent Developments
Table 88. Agilent Technologies, Inc. Company Details
Table 89. Agilent Technologies, Inc. Business Overview
Table 90. Agilent Technologies, Inc. Synthetic Oligonucleotides Product
Table 91. Agilent Technologies, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 92. Agilent Technologies, Inc. Recent Developments
Table 93. GE Healthcare Company Details
Table 94. GE Healthcare Business Overview
Table 95. GE Healthcare Synthetic Oligonucleotides Product
Table 96. GE Healthcare Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 97. GE Healthcare Recent Developments
Table 98. Kaneka Eurogentec S.A. Company Details
Table 99. Kaneka Eurogentec S.A. Business Overview
Table 100. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product
Table 101. Kaneka Eurogentec S.A. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 102. Kaneka Eurogentec S.A. Recent Developments
Table 103. GeneDesign, Inc. Company Details
Table 104. GeneDesign, Inc. Business Overview
Table 105. GeneDesign, Inc. Synthetic Oligonucleotides Product
Table 106. GeneDesign, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 107. GeneDesign, Inc. Recent Developments
Table 108. LGC Biosearch Technologies Company Details
Table 109. LGC Biosearch Technologies Business Overview
Table 110. LGC Biosearch Technologies Synthetic Oligonucleotides Product
Table 111. LGC Biosearch Technologies Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 112. LGC Biosearch Technologies Recent Developments
Table 113. Bio-synthesis Inc. Company Details
Table 114. Bio-synthesis Inc. Business Overview
Table 115. Bio-synthesis Inc. Synthetic Oligonucleotides Product
Table 116. Bio-synthesis Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 117. Bio-synthesis Inc. Recent Developments
Table 118. GeneWorks Pty Ltd Company Details
Table 119. GeneWorks Pty Ltd Business Overview
Table 120. GeneWorks Pty Ltd Synthetic Oligonucleotides Product
Table 121. GeneWorks Pty Ltd Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 122. GeneWorks Pty Ltd Recent Developments
Table 123. Integrated DNA Technologies, Inc Company Details
Table 124. Integrated DNA Technologies, Inc Business Overview
Table 125. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product
Table 126. Integrated DNA Technologies, Inc Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 127. Integrated DNA Technologies, Inc Recent Developments
Table 128. BioAutomation Company Details
Table 129. BioAutomation Business Overview
Table 130. BioAutomation Synthetic Oligonucleotides Product
Table 131. BioAutomation Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 132. BioAutomation Recent Developments
Table 133. Twist Bioscience Company Details
Table 134. Twist Bioscience Business Overview
Table 135. Twist Bioscience Synthetic Oligonucleotides Product
Table 136. Twist Bioscience Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 137. Twist Bioscience Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Oligonucleotides Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Synthetic Oligonucleotides Market Share by Type: 2022 VS 2033
Figure 3. Column-Based Oligos Features
Figure 4. Array-Based Oligos Features
Figure 5. Global Synthetic Oligonucleotides Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Synthetic Oligonucleotides Market Share by Application: 2022 VS 2033
Figure 7. Genetic Testing Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Synthetic Oligonucleotides Report Years Considered
Figure 11. Global Synthetic Oligonucleotides Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Synthetic Oligonucleotides Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Synthetic Oligonucleotides Market Share by Region: 2022 VS 2033
Figure 14. Global Synthetic Oligonucleotides Market Share by Players in 2022
Figure 15. Global Top Synthetic Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Synthetic Oligonucleotides Revenue in 2022
Figure 17. North America Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Synthetic Oligonucleotides Market Share by Type (2018-2033)
Figure 19. North America Synthetic Oligonucleotides Market Share by Application (2018-2033)
Figure 20. North America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 21. United States Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Synthetic Oligonucleotides Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Synthetic Oligonucleotides Market Share by Type (2018-2033)
Figure 25. Europe Synthetic Oligonucleotides Market Share by Application (2018-2033)
Figure 26. Europe Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 27. Germany Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Synthetic Oligonucleotides Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Synthetic Oligonucleotides Market Share by Type (2018-2033)
Figure 35. China Synthetic Oligonucleotides Market Share by Application (2018-2033)
Figure 36. Asia Synthetic Oligonucleotides Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Synthetic Oligonucleotides Market Share by Type (2018-2033)
Figure 38. Asia Synthetic Oligonucleotides Market Share by Application (2018-2033)
Figure 39. Asia Synthetic Oligonucleotides Market Share by Region (2018-2033)
Figure 40. Japan Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 50. Brazil Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Merck KGaA Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 58. Creative Biolabs Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 59. Danaher Corporation Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 60. Eurofins Scientific SE Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 61. Agilent Technologies, Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 62. GE Healthcare Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 63. Kaneka Eurogentec S.A. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 64. GeneDesign, Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 65. LGC Biosearch Technologies Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 66. Bio-synthesis Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 67. GeneWorks Pty Ltd Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 68. Integrated DNA Technologies, Inc Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 69. BioAutomation Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 70. Twist Bioscience Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries